-
-
Call more information
660-596-2224 -
Author: Helen Olkaba, MS ASA Monitor April 2023, Vol. 87, 31. Effective March 12, 2023, Cigna will reduce payment on services reported with modifier QZ by 15%. Modifier QZ identifies services provided by CRNAs without medical direction of a physician. According to Cigna, this was done to align payment with other advanced practice providers (e.g., nurse […]
Read MoreAuthor: Gundappa Neelakanta, MBBS ASA Monitor April 2023, Vol. 87, e4. “Here comes your margarita!” I hear the familiar words through the thin walls of the cubicle in the preoperative area as I talk to my patient on the other side of the cubicle. Their conversation then turned to, “It’s never too early for a drink” […]
Read MoreASA Monitor April 2023, Vol. 87, 12. The juvenile form of Pompe disease is MOST often associated with which of the following clinical abnormalities? □ (A) Micrognathia □ (B) Hypertrophic cardiomyopathy □ (C) Hypertonia Pompe disease is a disorder of carbohydrate metabolism and one of several glycogen storage diseases. The defective enzyme (acid α-glucosidase) impedes the breakdown of glycogen […]
Read MoreInternational Anesthesia Research Society The Daily Dose April 14, 2023 An Interview with Abstract Presenter and 2020 IARS Mentored Research Award Recipient – Dr. Michael Bokoch Michael Bokoch, MD, PhD During his fellowship, Michael Bokoch, MD, PhD, became intrigued by the high incidence of acute kidney injury after liver transplantation and the impact it has […]
Read MoreAuthor: Bennett K. Pract Pain Manag. 2023 March/April;22(2). Regular users of cannabis may have more pain and nausea after surgery. What anesthesiologists need to ask and adjust as part of perioperative care. The American Society of Regional Anesthesia and Pain Medicine (ASRA) released new guidelines in early 2023 on the management of perioperative patients on […]
Read MoreASA Monitor April 2023, Vol. 87, 11–15. Trends Experimental vaccine shows promising results in first-in-human study against Marburg virus An experimental vaccine against Marburg virus (MARV) developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), was found to be safe and induced an immune […]
Read MoreAuthor: Deborah Greif ASA Monitor April 2023, Vol. 87, 28. ASA’s dedication to safe patient care is steadfast. Our members work to provide every patient the best possible care, every day. ASA works tirelessly to support our members’ important work and to help them tackle the many challenges they face. Our corporate relations program is an […]
Read MoreAuthors: Joseph M. Hendrix, MD, FASA, FASE, F-SAMBA et al ASA Monitor April 2023, Vol. 87, 40–42. Medical misinformation and disinformation targeting various audiences have increased worldwide over the past years. The internet, social media, and search algorithms often lead users to increasingly polarized viewpoints. As a consequence, we have unlimited data and information, false and […]
Read MoreAuthors: Smitha Arekapudi, MD, MBA, ScM, FASA et al ASA Monitor April 2023, Vol. 87, 43–45. Each year, more than 40 million anesthetics are provided to patients in the United States. Between changes in payment patterns, supply chain challenges, and increasing demand for anesthesiology services, anesthesiologists are under increasing pressure to do more with less. This drive […]
Read MoreAuthors: Fritz-Gerald Charles, MD, CNMT et al ASA Monitor April 2023, Vol. 87, 18–19. The old adage “You never get a second chance to make a first impression” applies daily in the practice of anesthesiology. The field is marked by brief encounters with patients during some of their most stressful life events: before the birth of […]
Read More